Sign in

You're signed outSign in or to get full access.

Aaron Green

Aaron Green

Chief Executive Officer at OneMedNet
CEO
Executive
Board

About Aaron Green

Aaron Green is a healthcare IT executive with 20+ years of experience across cloud solutions, sales leadership, and business transformation. He has served as ONMD’s Chief Executive Officer and a Director since March 29, 2024, and as President since May 2023; age 52 as of November 7, 2025 . Education: B.Sc. in Biochemistry (University of Victoria), Systems Analyst Diploma (Royal Roads University), and Executive MBA (Wharton) . Company performance signals during his tenure include onboarding four new large strategic partners that nearly doubled the clinical data network and contributed to 15% year-over-year bookings growth early in 2024, with later disclosures citing substantial bookings momentum into 2025 .

Past Roles

OrganizationRoleYearsStrategic Impact
Optum (UnitedHealth Group)Vice President, Cloud SolutionsNot disclosedP&L responsibility for Cloud Solutions lines; accountable for Bookings, Revenue, and EBITDA targets .
Change HealthcareVice President, Cloud SolutionsMar 2021–May 2023Led cloud solutions for ~2 years within a 6-year tenure at Change Healthcare .
Change HealthcareVarious rolesMar 2017–Mar 2021Progressed into VP Cloud Solutions; cumulative ~6 years at company .
McKessonDivision Vice President, Sales15+ years (dates not disclosed)Led 50+ executives and staff across US, Canada, and US territories; large-scale sales leadership .

External Roles

OrganizationRoleYearsNotes
No outside public-company directorships or external board roles disclosed in ONMD proxy materials for Mr. Green .

Fixed Compensation

Metric20232024
Base Salary ($)213,512 350,000
Target Bonus ($)Up to 175,000 (as per employment agreement) Up to 175,000 (as per employment agreement)
Target Bonus (% of Salary)Derived: ~82% of 2023 salary (175,000 on 213,512) based on agreement; company cites amount not percent Derived: 50% of salary (175,000 on 350,000); company cites amount not percent
Actual Bonus Paid ($)106,435 0 (no bonuses approved for 2024)

Notes:

  • Employment agreement provides eligibility for an annual cash performance bonus of up to $175,000 upon achievement of performance goals .
  • 2024 bonuses were not approved for any NEOs .

Performance Compensation

Annual Cash Bonus Plan (2024)

ElementDetails
Metric FrameworkBonuses may be awarded based on qualitative and quantitative performance standards (specific metrics not disclosed) .
TargetUp to $175,000 (see Fixed Compensation) .
Weighting by MetricNot disclosed .
Payout (2024)$0; no bonuses approved for 2024 .
ClawbackCompany adopted a clawback policy in Nov 2024; applies to erroneously awarded incentive compensation for current/former executive officers covering 3 fiscal years prior to a required restatement, and allows clawback for employee misconduct events .

Long-Term Equity (Time-based RSUs)

Grant DateTypeShares GrantedVesting ScheduleGrant-Date Fair Value/Reporting
Jan 20, 2024RSUs600,000 1/3 vests on first anniversary of vest start date (May 23, 2024); remaining vests in equal monthly installments over 24 months thereafter through May 2026, subject to continuous service .2024 “Stock awards” reported for Mr. Green: $258,000 (ASC 718) .
Outstanding at 12/31/2024RSUs (unvested)283,333 As above; monthly vesting underway post-May 2024 .Market value at 12/31/2024: $385,333 (based on $1.36 close) .

Notes:

  • No option awards to Mr. Green disclosed for 2023–2024; prior CEO Paul Casey had options at $1.00 strike upon retirement; Green did not .

Multi-Year Compensation Summary

YearSalary ($)Bonus ($)Stock Awards ($)Total ($)
2023213,512 106,435 319,947
2024350,000 258,000 608,000

Equity Ownership & Alignment

As-Of DateBeneficially Owned Shares (#)Percent of Class (%)Notable Components
Oct 31, 2024449,252 1.6% Includes 233,296 shares from Pre-Closing PIPE Notes and 15,956 underlying warrants; see footnote (4) .
Oct 23, 2025601,381 1.2% Includes 15,956 PIPE-related warrants and 345,000 shares underlying vested/vesting-within-60-days RSUs .
Dec 31, 2024Unvested RSUs: 283,333 Market value $385,333 at $1.36 close .

Additional alignment policies and risk controls:

  • Hedging and short-term speculative transactions (including short sales, puts, calls, and cashless collars) are prohibited under ONMD’s Insider Trading Policy; trading during blackout periods requires permission .
  • Pledging: The “Hedging and Pledging Transactions” section describes hedging prohibitions; an explicit pledging prohibition is not stated in the cited text .
  • Stock ownership guidelines: Not disclosed in the proxy excerpts; committee charters and governance materials are referenced on the company website .

Implications for vest-driven selling pressure:

  • RSUs vest monthly through May 2026; as of 12/31/2024, 283,333 RSUs remained unvested, implying a steady cadence of vesting that can create periodic liquidity events for the executive and potential incremental float overhang if sold .

Employment Terms

TermDetail
Employment StatusAt-will; employment agreement executed (initially entered May 7, 2023) .
Base Salary$350,000 (2024) .
Target Annual BonusUp to $175,000, subject to achievement of performance goals .
Severance (non‑CoC)If terminated without Cause or resigns for Good Reason: after 6–12 months of service → 3 months’ salary; after ≥12 months → 6 months’ salary, subject to execution of a standard release .
Change-of-ControlNot disclosed in cited filings .
ClawbackPolicy adopted in Nov 2024; recovery of erroneously awarded incentive comp for executive officers for 3 fiscal years prior to a restatement; also allows clawback for employee misconduct .
IndemnificationCompany to enter into standard indemnification agreement with Mr. Green per appointment 8-K .
Non-Compete/Non-SolicitNot disclosed in cited filings .

Board Service & Governance

  • Board Service: Appointed to ONMD’s Board effective March 29, 2024; Class I nominee in 2024 proxy cycle; serves as CEO, President, and Director .
  • Chair/Independence: Mr. Green is management (not independent). The Chairman role is held by Dr. Jeffrey Yu (Founder, CMO, VP, Chairman) . All Board committees (Audit, Compensation, Nominating & Corporate Governance) are comprised solely of independent directors .
  • Committee Roles: No committee assignments disclosed for Mr. Green; independent-only committee composition implies executives (including CEO) do not serve on committees .
  • Attendance: In 2024, the Board held two meetings; no director attended fewer than 75% of Board and committee meetings . In 2023 (post-business combination), Board held one meeting .

Dual-role implications:

  • CEO + Director structure is common but raises independence considerations; ONMD mitigates via independent-only committees and separate Chairman (Dr. Yu), with committee charters posted on the company website .

Related Party Transactions (Context for Alignment/Conflicts)

  • PIPE Notes and Warrants: Related party investors (including Mr. Green) participated in pre-closing PIPE notes. In June 2025, holders (including Mr. Green) converted ~$1.66M of Pre-Closing PIPE Notes into 1,453,174 shares at $1.14 per share . Footnotes in ownership tables also reflect PIPE-related warrants held by Mr. Green .

Performance & Track Record

  • Early tenure outcomes: Company disclosed addition of four new large strategic partners in 2024, nearly doubling the clinical data network and contributing to bookings growth of 15% YoY at that time .
  • Momentum: Subsequent 2025 update cited an 815% bookings increase and a 4.5x increase in another key metric, indicating significant commercial traction; these are company-wide metrics during his leadership period .

Investment Implications

  • Pay-for-performance alignment: The 2024 pay mix tilted toward equity (time-based RSUs) with no cash bonus payout; the structure keeps more compensation at-risk via vesting rather than annual cash, though lack of disclosed performance metrics for the bonus limits transparency on bonus goal rigor .
  • Vesting overhang: Monthly RSU vesting through May 2026 creates a predictable cadence of potential insider liquidity; as of 12/31/2024, 283,333 RSUs remained unvested (market value ~$385k at $1.36), which can contribute to intermittent selling pressure depending on 10b5-1 plans and personal diversification .
  • Ownership alignment: Mr. Green’s beneficial ownership stands at 1.2% as of Oct 23, 2025 (including vested/near-term RSUs and PIPE-related warrants), up from 1.6% of a smaller base in 2024; meaningful equity stake and prior PIPE participation suggest alignment, though overall stake remains modest versus total shares outstanding .
  • Governance controls: Independent-only committees, hedging prohibitions, and a formal clawback policy adopted in 2024 are positive governance signals; absence of explicit pledging prohibition in the cited text leaves a residual alignment risk if pledging were ever used, though no pledging was disclosed .
  • Retention risk: Severance economics are modest (3–6 months base salary depending on service duration), which may limit “golden handcuff” retention but could be shareholder-friendly by capping termination costs; no change-of-control protections were disclosed in the cited materials .
Key near-term watch items: (i) Form 4s for any sales around monthly RSU vest dates, (ii) bonus framework/magnitude for 2025+ once performance metrics are disclosed, (iii) continued bookings conversion to revenue and cash flow as commercialization scales, and (iv) any updates to ownership policies (pledging, ownership guidelines).
``` **[1849380_0001493152-25-021265_formdef14a.htm:31]** **[1849380_0001493152-25-021265_formdef14a.htm:22]** **[1849380_0001493152-25-021265_formdef14a.htm:33]** **[1849380_0001493152-25-021265_formdef14a.htm:35]** **[1849380_499100ff9a6e4c0db88602f0f472adc6_0]**